Ophthalmia Neonatorum: Causes, Symptoms, and Treatment

Ophthalmia neonatorum is an eye infection in newborns, typically appearing within the first month of life, that causes redness, swelling, and discharge from one or both eyes. It can be triggered by bacteria, viruses, or even the chemical drops used to prevent it. The condition ranges from mild and self-limiting to sight-threatening, depending almost entirely on which organism is responsible. A systematic review and meta-analysis estimated the global incidence at about 2%, though rates in low-income countries are roughly five times higher than in wealthy ones.¹

What Causes It

The causes fall into three broad categories: bacterial, viral, and chemical. Bacterial infections account for the vast majority of cases and are the ones clinicians worry about most. Of the bacterial causes, Chlamydia trachomatis and Neisseria gonorrhoeae are the two organisms most frequently linked to serious disease.² A global survey of ophthalmologists found Chlamydia trachomatis to be the single most commonly reported pathogen, identified in about a third of cases.³ That said, the specific organisms vary enormously by region and hospital setting. In many nurseries, less dangerous bacteria like coagulase-negative Staphylococcus species are actually the most frequently isolated organisms, outnumbering the headline pathogens.⁴ The same systematic review that estimated global incidence also found Staphylococcus species and Serratia marcescens to be the bacteria most frequently isolated overall.¹

Viral causes are less common but still clinically important. Herpes simplex virus (types 1 and 2) and adenovirus are the main culprits.⁵ Herpes-related eye infections in newborns deserve special attention because they can be part of a broader systemic herpes infection, and they do not respond to the antibiotics typically given first. Clinicians are urged to consider herpes when a newborn’s conjunctivitis includes an epithelial defect on the cornea and fails to improve with standard antibiotic drops.⁶

Chemical conjunctivitis rounds out the list of causes, and it is uniquely ironic: it results from the very drops applied to prevent infection. Silver nitrate solution, the original prophylactic agent introduced in the 1800s, is well known for causing irritation, pain, and a chemical conjunctivitis in the hours after application.⁷ This side effect is one reason many developed countries have moved away from silver nitrate altogether.²

How Babies Get Infected

Infection can occur through three routes: before birth (intrauterine), during delivery (peripartum), or after birth (postnatal).⁵ The overwhelming majority of cases come from exposure during passage through the birth canal, where the baby’s eyes come into direct contact with infected genital secretions. This is why maternal sexually transmitted infections, particularly gonorrhea and chlamydia, are the most important risk factors. Reducing sepsis, traumatic deliveries, and undiagnosed STIs in the mother through improved prenatal care has been identified as a key strategy for lowering rates of vertical transmission.⁸

Postnatal transmission is less common but does happen. Hospital staff, family members, or contaminated surfaces can introduce organisms to the baby’s eyes after birth. Herpes simplex can be transmitted postnatally through contact with an active lesion, for instance on a caregiver’s lip. This is worth knowing because parents sometimes assume that only delivery-related exposure matters.

What It Looks Like and When It Appears

The hallmark symptoms are eyelid swelling, redness, and discharge from one or both eyes. Beyond that general picture, the timing and severity differ based on the causative organism, and the timing itself is one of the first clinical clues to the cause.

Chemical conjunctivitis from prophylactic drops appears earliest, usually within the first 24 to 48 hours of life. It tends to be mild, with watery discharge and moderate redness, and resolves on its own within a few days without treatment.

Gonococcal ophthalmia neonatorum is the most aggressive form. It can develop as quickly as 24 hours after birth, producing severe lid swelling and copious, thick purulent discharge.⁹ The eyelids can become so swollen that they are difficult to open. This form progresses rapidly and is a true ophthalmic emergency.

Chlamydial conjunctivitis takes longer to declare itself, typically appearing between 5 and 14 days after birth. The discharge tends to be watery to mucopurulent (somewhere between clear and pus-like), and the lids swell less dramatically than with gonococcal infection. Chlamydial disease can look deceptively mild, which is part of its danger: parents and even clinicians sometimes underestimate it.

Herpes simplex conjunctivitis usually shows up within the first two weeks and may present with a watery discharge, lid vesicles (small blisters), and sometimes a visible defect on the corneal surface. Because a herpes eye infection in a newborn can be a sign of disseminated herpes disease affecting the brain and other organs, any suspicion warrants urgent evaluation.

Why Gonococcal Infection Is an Emergency

Neisseria gonorrhoeae attacks the cornea with unusual speed. It can cause corneal scarring, perforation of the eye, and irreversible blindness, sometimes within a day of symptoms appearing.⁹ A case series of patients with gonococcal keratoconjunctivitis underscored that the condition can progress to full corneal perforation and endophthalmitis (infection inside the eye), reinforcing the need for early recognition and immediate referral to an ophthalmologist.¹⁰ No other common cause of neonatal conjunctivitis destroys tissue this fast.

Chlamydia and the Risk Beyond the Eyes

Chlamydial conjunctivitis is not just an eye problem. When Chlamydia trachomatis infects a newborn’s eyes during delivery, it frequently colonizes the respiratory tract as well. Research published in the New England Journal of Medicine found nasopharyngeal chlamydia in 18 of 20 infants who developed a distinctive pneumonia syndrome, and in 10 of 12 infants who had inclusion conjunctivitis alone. Antibody levels in infants with pneumonia were dramatically higher than in those with conjunctivitis only.¹¹ This is a big part of the reason treatment for chlamydial eye infection requires systemic (oral) antibiotics rather than just eye drops: topical treatment can clear the conjunctival infection while leaving the organism happily colonizing the nose and throat, setting the stage for pneumonia weeks later.

How It Is Diagnosed

Diagnosis starts with clinical examination. A swollen, discharging eye in a newborn under 28 days old is ophthalmia neonatorum until proven otherwise. From there, laboratory testing helps pin down the specific organism, which matters because treatment differs substantially by cause. Standard diagnostic methods include Gram stain, bacterial culture, immunofluorescence testing, and nucleic acid amplification tests (NAATs, essentially DNA-based detection).¹²¹³

Gram stain is particularly useful for gonococcal infection because the characteristic gram-negative diplococci (pairs of kidney-shaped bacteria) can often be seen within the first minutes of lab work, allowing treatment to begin immediately. Chlamydia, being an intracellular organism, does not show up on routine Gram stain; NAAT testing is the most sensitive way to detect it. Culture remains important, especially for confirming antibiotic susceptibility, though it takes longer to yield results.

Not Every Sticky Eye Is an Infection

One common source of parental anxiety is the sticky, watery eye that appears in the first weeks of life. Many of these turn out to be caused by a blocked nasolacrimal duct (the tear drainage channel between the eye and the nose), not by infection at all. Nasolacrimal duct obstruction is common and benign, affecting a substantial fraction of newborns. The BMJ notes that distinguishing this from true conjunctivitis is important for avoiding unnecessary referrals and undue worry for new parents.¹⁴ The key differences: a blocked duct typically produces a watery or slightly mucousy discharge without significant redness or lid swelling, and it tends to be chronic and intermittent rather than acute. True ophthalmia neonatorum, by contrast, features redness, definite swelling, and discharge that is often thicker and more profuse.

Treatment by Cause

Because the danger level and treatment differ dramatically depending on the pathogen, identifying the cause quickly drives every management decision.

Gonococcal Ophthalmia Neonatorum

Gonococcal infection requires systemic antibiotics, not just eye drops. A landmark trial showed that a single intramuscular dose of ceftriaxone (125 mg) cured all 55 newborns who returned for follow-up, both clinically and microbiologically. Ceftriaxone also cleared gonococcal infection from the throat in all 18 infants found to have oropharyngeal colonization, without any need for additional topical antibiotics.¹⁵ In current practice, ceftriaxone remains the standard treatment in most guidelines, though exact dosing and any additional agents can vary by institution. Frequent saline irrigation of the eye is also commonly performed to physically wash out the organism.

Chlamydial Ophthalmia Neonatorum

Oral antibiotics are essential here. The reason is the one discussed earlier: topical drops may clear the eye but leave chlamydia in the respiratory tract. A systematic review and meta-analysis of treatment studies found that a 14-day course of oral erythromycin (at 50 mg/kg body weight per day) achieved clinical cure in about 96% of neonates and microbiological cure in about 97%. The main downside was gastrointestinal side effects in roughly 14% of treated infants. Azithromycin showed promise as a shorter alternative, with a three-day course achieving about 86% microbiological cure, though a single dose performed less well at about 60%.¹⁶ Earlier research confirmed that oral erythromycin eradicated chlamydia from both the conjunctiva and the nasopharynx in about 93% of treated infants, while topical treatment alone left many infants with persistent nasopharyngeal colonization.¹⁷

Herpes Simplex

Suspected herpes eye infection in a newborn is treated with systemic antiviral medication, typically intravenous acyclovir, along with topical antiviral eye drops. Because neonatal herpes can disseminate to the brain and other organs, treatment is aggressive and initiated on clinical suspicion rather than waiting for confirmatory testing. If antibiotics have already been started and the eye is not improving, herpes should be considered.⁶

Other Bacterial and Chemical Causes

Conjunctivitis caused by common skin bacteria like Staphylococcus species is usually less severe and often responds to topical antibiotic drops or ointment. Chemical conjunctivitis from prophylactic drops needs no treatment at all; it resolves on its own within one to two days.

Preventing Ophthalmia Neonatorum

Prevention operates on two fronts: screening and treating the mother before delivery, and applying prophylactic drops to the baby’s eyes at birth.

Maternal screening is considered the most effective single strategy. Testing pregnant women for chlamydia and gonorrhea, and treating infections before delivery, directly removes the source of exposure. A Canadian study found that about 82% of mothers in a large birthing centre were screened at least once with a valid result by the day of delivery, and infection was detected in about 2% of those screened.¹⁸ That screening rate, while substantial, means nearly one in five women were not screened, highlighting a persistent gap even in well-resourced settings.

Ocular prophylaxis at birth has a long history. Silver nitrate was the original agent, introduced in the late 1800s to combat gonococcal blindness, and many jurisdictions made its use mandatory by law. In the preantibiotic era, this was a major public health achievement. Over time, erythromycin ointment and povidone-iodine solution emerged as alternatives. A large controlled trial compared all three head-to-head: povidone-iodine performed best overall, with roughly 13% of treated newborns developing infectious conjunctivitis compared to about 18% in the silver nitrate group and 15% in the erythromycin group. Povidone-iodine was also more effective against Chlamydia specifically, and it caused less chemical irritation than either alternative.¹⁹ A meta-analysis similarly found that erythromycin and povidone-iodine both outperformed silver nitrate against chlamydial ophthalmia specifically, though no agent showed a statistically significant advantage against gonococcal disease.²⁰

The Growing Debate Over Routine Prophylaxis

The practice of applying erythromycin ointment to every newborn’s eyes at birth, still standard in many North American hospitals, is coming under increasing scrutiny. Several countries including the United Kingdom, Sweden, Norway, and Denmark discontinued routine ocular prophylaxis years ago, relying instead on robust prenatal screening programs to catch and treat maternal infections before delivery.

The arguments against continuing universal prophylaxis have sharpened. Concerns about antimicrobial resistance, medication supply shortages, and the potential disruption of the newborn gut and ocular microbiome are fueling questions about whether the policy still makes sense in settings with reliable prenatal screening.²¹ Gonococcal ophthalmia neonatorum has become rare in high-income countries, which weakens the risk-benefit calculation for universal prophylaxis. The U.S. Preventive Services Task Force has continued to recommend prophylaxis, though it acknowledges the evidence base is old and the epidemiologic landscape has shifted.⁹

The tension is real: in settings where maternal screening is incomplete or unavailable, prophylaxis remains a critical safety net. The global incidence numbers bear this out, with rates in low-income countries around 7% compared to about 1.4% in high-income ones.¹ Abandoning prophylaxis where screening infrastructure is weak would expose more newborns to preventable blindness. The likely future is not one-size-fits-all, but rather policies calibrated to regional screening capacity and STI prevalence.

Why the Pathogen Mix Varies So Much by Setting

One of the more striking features of ophthalmia neonatorum research is how dramatically the microbiological picture changes depending on where you look. In sub-Saharan Africa, gonococcal disease still accounts for a meaningful share of cases. In Western Europe and North America, Staphylococcus and other common skin flora dominate, with chlamydia making up a significant minority and gonorrhea becoming genuinely rare. Some of this reflects screening success. When pregnant women are routinely tested and treated for gonorrhea and chlamydia, those organisms become less common in neonatal infections, and the proportional share of “ordinary” bacteria rises. Some of it reflects population-level STI rates. And some of it reflects laboratory practices: facilities that do not routinely test for chlamydia will report lower chlamydia rates, not necessarily because the organism is absent but because it is not being looked for.

This variation matters because it shapes local treatment guidelines. A hospital where gonorrhea has not been seen in neonatal conjunctivitis for a decade may approach a red, swollen newborn eye differently than one where gonococcal disease appears monthly. But the unpredictability of individual cases means that aggressive early testing remains important everywhere. A single missed gonococcal infection can cause permanent damage before the culture results come back.

1
PubMed Central. Epidemiology of ophthalmia neonatorum: a systematic review and meta-analysis
2
PubMed Central. Neonatal conjunctivitis – a review
3
PubMed. Ophthalmia neonatorum treatment and prophylaxis: IPOSC global study
4
Indian Journal of Pathology and Microbiology. Conjunctivitis in the newborn- A comparative study
5
Andes pediátrica. Neonatal ophthalmia caused by Herpes Simplex Virus type I
6
PubMed Central. Congenital herpes simplex with ophthalmic and multisystem features: a case report
7
PubMed Central. Silver nitrate prophylaxis
8
PubMed Central. Maternal and neonatal risk factors associated with vertical transmission of ophthalmia neonatorum in neonates receiving health care in Blantyre, Malawi
9
JAMA. Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: US Preventive Services Task Force Reaffirmation Recommendation Statement
10
PubMed Central. Perforated Corneal Ulcer Arising From Gonococcal Keratoconjunctivitis: A Report of Three Cases
11
PubMed. Respiratory-tract colonization and a distinctive pneumonia syndrome in infants infected with Chlamydia trachomatis
12
PubMed Central. Predictors of Chlamydia trachomatis conjunctivitis in neonates: a 10-Year retrospective study
13
IMAN MEDICAL JOURNAL. Diagnosis and antimicrobial therapy of neonatal conjunctivitis: a mini review
14
BMJ. Approach to conjunctivitis in newborns
15
PubMed. Single-dose therapy of gonococcal ophthalmia neonatorum with ceftriaxone
16
PubMed Central. Treatment of Neonatal Chlamydial Conjunctivitis: A Systematic Review and Meta-analysis
17
PubMed. Topical sulfacetamide vs oral erythromycin for neonatal chlamydial conjunctivitis
18
PubMed Central. Suboptimal prenatal screening of Chlamydia trachomatis and Neisseria gonorrhoeae infections in a Montréal birthing and tertiary care centre: A retrospective cohort study
19
PubMed. A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum
20
PubMed. A meta-analysis of the efficacy of ocular prophylactic agents for the prevention of gonococcal and chlamydial ophthalmia neonatorum
21
PubMed. Reevaluating Neonatal Erythromycin Prophylaxis Policy Amid Advances in Sexually Transmitted Infection Screening, Antenatal Treatment, and Antibiotic Stewardship